Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma

Author(s):: Lange, J. de; Ly, L.V.; Lodder, K.; Verlaan-de Vries, M.; Teunisse, A.F.A.S.; Jager, M.J.; Jochemsen, A.G. (0000-0002-0570-7967)

Published: 2012
Publication type: Article / Letter to editor

uveal melanomap53Nutlin-3RITAtopotecanhypoxia

Date issued: 2012-03-31
Language: English
Is part of: Oncogene (2012), Vol. 31, no. 9, p. 1105-1116
hdl: 1887/99255
doi: 10.1038/onc.2011.309